Sun Pharma Advanced Research Company (SPARC) is a clinical stage bio-pharmaceutical company focused on continuously improving standards of care for patients globally, through innovation in therapeutics and delivery. SPARC was formed in 2007 through a demerger from SUN PHARMA, a global leader in speciality generics. We strive to build an enduring innovation engine built on strong scientific execution, high value analytics and aggressive portfolio management.
A robust mix of internal ideation and strategic partnering with academic innovators and bio-pharma entrepreneurs fuel our engine with potentially high impact ideas. We partner with thought-leading clinicians across the world for ideas and access. Innovation through integration of partner knowledge and efficient internal execution shapes our future.